(Q39454742)

12 September 2017

title

Prostaglandins and breast cancer. (English)

1 reference

12 September 2017

1 reference

A Bennett

1

1 reference

12 September 2017

E M Charlier

2

1 reference

12 September 2017

A M McDonald

3

1 reference

12 September 2017

J S Simpson

4

1 reference

12 September 2017

I F Stamford

5

1 reference

12 September 2017

T Zebro

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 September 1977

1 reference

12 September 2017

1 reference

12 September 2017

volume

2

1 reference

12 September 2017

issue

8039

1 reference

12 September 2017

page(s)

624-626

1 reference

Breast cancer, prostaglandins, and bone metastases

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Bone destruction by breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Prostaglandin E2 and gastric acid secretion in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Extraction of Prostaglandins from Human Blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Prostaglandins released by the Spleen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Preliminary experience of bone scanning with 99mTc-labelled polyphosphate in malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Hypercalcemia and tumor-prostaglandins: The VX2 carcinoma model in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Metabolism of prostaglandins A1 and E1 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Subversion of immune system by tumor cells and role of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in balb/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

Mechanisms of bone destruction in the development of skeletal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992496-5

7 January 2021

10.1016/S0140-6736(77)92496-5

Identifiers

DOI

1 reference

12 September 2017

1 reference